SXTP NASDAQ
60 Degrees Pharmaceuticals, Inc.
1W: +18.8%
1M: +46.4%
3M: -17.3%
YTD: -32.5%
1Y: -5.4%
3Y: -97.0%
$1.39
+0.14 (+11.20%)
Weekly Expected Move ±12.4%
$1
$1
$1
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+65.5% ▲
5Y CAGR: -14.3%
Gross Profit
$224K
+0.4% ▲
5Y CAGR: -31.5%
Operating Income
-$8M
+20.1% ▲
Net Income
-$7M
+7.3% ▲
EPS (Diluted)
$-11.73
+84.2% ▲
EBITDA
-$8M
+1.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1M | $223K | $254K | $608K | $1M |
| YoY Growth | -46.8% | -80.8% | +13.6% | +139.6% | +65.5% |
| Cost of Revenue | $851K | $432K | $475K | $385K | $782K |
| Gross Profit | $310K | -$209K | -$221K | $223K | $224K |
| Gross Margin | 26.7% | -93.7% | -87.1% | 36.7% | 22.3% |
| R&D Expenses | $6M | $526K | $692K | $5M | $2M |
| SG&A Expenses | $1M | $1M | $4M | $5M | $6M |
| Operating Expenses | $1M | $2M | $5M | $10M | $8M |
| Operating Income | -$1M | -$2M | -$5M | -$10M | -$8M |
| Operating Margin | -96.9% | -784.2% | -2032.8% | -1599.0% | -771.6% |
| Interest Expense | $3M | $4M | $2M | $8K | -$8K |
| Income Before Tax | -$4M | -$6M | -$4M | -$8M | -$7M |
| Tax Expense | $1K | $500 | $250 | $250 | $0 |
| Net Income | -$4M | -$6M | -$4M | -$8M | -$7M |
| Net Margin | -366.4% | -2769.5% | -1485.1% | -1308.0% | -732.8% |
| EPS (Diluted) | $-0.74 | $-1.07 | $-0.95 | $-18.55 | $-11.73 |
| EBITDA | -$1M | -$2M | -$1M | -$8M | -$8M |
| Shares Outstanding | 6M | 6M | 4M | 454582 | 670211 |